FDA Import Refusal AEK-8216980-4/11/1 — GLAXOSMITHKLINE

GLAXOSMITHKLINE — FEI 3021212279

The FDA refused shipment AEK-8216980-4/11/1 from GLAXOSMITHKLINE (Canada) on Feb 18, 2025. The refused product falls under Drugs and Biologics — BELIMUMAB. Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal details

Date
Feb 18, 2025
Country
Canada
Product Category
Drugs and Biologics
Product Code
58MCY20 BELIMUMAB
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.